Cargando…
ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer
ARID1A is a key component of the SWI/SNF chromatin remodeling complexes which is important for the maintaining of biological processes of cells. Recent studies had uncovered the potential role of ARID1A alterations or expression loss in the therapeutic sensitivity of cancers, but the studies in this...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555283/ https://www.ncbi.nlm.nih.gov/pubmed/34715776 http://dx.doi.org/10.1186/s10020-021-00400-5 |